Research Breakthrough: At The Ohio State University Medical Center, researchers found that among people diagnosed with an early ovarian cancer precursor, older patients and Black patients face worse survival, underscoring the urgent need for more tailored care and treatment strategies.
Serous tubal intraepithelial carcinoma (STIC) is a rare lesion in the fallopian tube that is believed to be a precursor to high-grade serous ovarian cancer, the most common and aggressive type of ovarian cancer.
Using data from over 1,000 patients across the U.S., researchers at the Ohio State University Medical Center compared those diagnosed with STIC as their first cancer to those who developed it after another cancer. They found notable differences: people with first-time STIC were younger, more likely to be privately insured, and more often treated in the South, while those with later STIC were typically older, more likely to be non-White, have more health problems, and receive care at academic hospitals in the Northeast.
The study also showed that survival outcomes were strongly tied to age and race. Black patients and patients diagnosed at age 70 or older had poorer survival outcomes, even after adjusting for other factors. In contrast, treatments like chemotherapy or complete surgical staging did not appear to improve survival.
These findings highlight that demographic factors—particularly age and race—play an important role in outcomes for STIC, and that more research is needed to guide treatment decisions and improve equity in care.
Read more:
Prognostic and demographic patterns in serous tubal intraepithelial carcinoma: A National Cancer Database study, published in Gynecologic Oncology in October 2025.
Ovarian Cancer Research Alliance (OCRA) Support
OCRA Grantee Co-Authors include Laura Chambers, DO, The Ohio State University.
